Treatment of Canine Type 1 Diabetes Mellitus: The Long Road from Twice Daily Insulin Injection towards Long-Lasting Cell-Based Therapy

Bibliographic Details
Title: Treatment of Canine Type 1 Diabetes Mellitus: The Long Road from Twice Daily Insulin Injection towards Long-Lasting Cell-Based Therapy
Authors: Flavia C. M. Oliveira, Annemarie W. Y. Voorbij, Elisa C. Pereira, Leonor M. M. Alves e Almeida, Geanne R. Moraes, Joana T. De Oliveira, Boyd H. T. Gouw, Sabrina A. M. Legatti, Hans S. Kooistra, Bart Spee, Andre M. C. Meneses, Louis C. Penning
Source: Organoids, Vol 3, Iss 2, Pp 67-82 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Cytology
Subject Terms: dogs, insulin, pancreas, organoids, regenerative medicine, Cytology, QH573-671
More Details: For over 150 years, researchers have studied the (patho)physiology of the endocrine pancreas and devised treatment options for diabetes mellitus (DM). However, no cure has been developed so far. In dogs, diabetes mellitus type 1 (T1DM) is the most common presentation. Treatment consists of twice daily insulin injections, monitored by spatial blood glucose measurements. Even though dogs were instrumental in the discovery of insulin and islet transplantations, the treatment in diabetic dogs has remained unchanged for decades. Providing twice daily insulin injections is demanding for both owners and dogs and may result in hypoglycaemic events, creating the need for new treatment strategies. Novel regenerative medicine-based tools, such as improved β-cell culture protocols and artificial devices, have sparked hope for a cure. In human medicine, emerging technologies such as the transplantation of insulin-producing β-cells, generated by stem cell differentiation, with or without an encapsulation device, are currently tested in phase I/II clinical trials. As the pathogenesis of T1DM is remarkably similar between humans and dogs, novel treatment methods could be implemented in canine medicine. This review briefly summarises the physiology of the canine endocrine pancreas and the pathophysiology of canine DM before exploring current and possible future treatment options for canine DM.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2674-1172
Relation: https://www.mdpi.com/2674-1172/3/2/6; https://doaj.org/toc/2674-1172
DOI: 10.3390/organoids3020006
Access URL: https://doaj.org/article/c769440975544fbebe1a015a09f86e68
Accession Number: edsdoj.769440975544fbebe1a015a09f86e68
Database: Directory of Open Access Journals
More Details
ISSN:26741172
DOI:10.3390/organoids3020006
Published in:Organoids
Language:English